Cargando…
HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins
SIMPLE SUMMARY: High-risk strains of human papillomavirus (HPV) such as HPV16 cause anogenital and oropharyngeal cancers, with HPV-associated cervical cancer being the fourth most common cancer worldwide and a major cause of death for women. Anti-HPV vaccines are available but coverage is low, and w...
Autores principales: | Park, Soyeong, Auyeung, Andrew, Lee, Denis L., Lambert, Paul F., Carchman, Evie H., Sherer, Nathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956332/ https://www.ncbi.nlm.nih.gov/pubmed/33668328 http://dx.doi.org/10.3390/cancers13050949 |
Ejemplares similares
-
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease
por: Gunder, Laura C., et al.
Publicado: (2023) -
An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein
por: Belyaeva, Tamara A., et al.
Publicado: (2014) -
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer
por: Rho, Seung Bae, et al.
Publicado: (2020) -
Molecular Landscape and Computational Screening of the Natural inhibitors against HPV16 E6 Oncoprotein
por: Juneja, Tanzil, et al.
Publicado: (2021) -
HPV16 AND EXPRESSION OF PROTEIN P16(INK4A) AND E7
ONCOPROTEIN IN COLORECTAL CARCINOMA
por: PICANÇO-JUNIOR, Olavo Magalhães, et al.
Publicado: (2022)